Search

The hand grip test has been correlated with mobility and physical performance in older people and has been shown to be a long-term predictor of mortality. Implementation of new strategies for enhancing healthy aging and maintaining independent living are dependent on predictable preclinical studies. The mouse is used extensively as a model in these types of studies, and the paw grip strength test is similar to the hand grip test for people in that it assesses the ability to grip a device with the paw, is non-invasive and easy to perform, and provides reproducible information. However, little has been reported on how grip strength declines with increasing age in mice. This report shows that grip strength was decreased in C57BL/6 (B6) NIA and C57BL/6BALB/c F1 (CB6F1) NIA male mice at 12 months of age compared to 8-month-old mice, and continued a robust decline to 20 months and then 28 months of age, when the study was terminated. The decline was not related to lean muscle mass, but extensive age-related carpal and digital exostosis could help explain the decreased grip strength times with increasing age. In conclusion, the grip strength test could be useful in mouse preclinical studies to help make translational predictions on treatment strategies to enhance healthy aging. [ABSTRACT FROM AUTHOR]

The article presents an overview of a model of chronic hepatitis in a four-month-old mice expressing a truncated XRCC1 protein. Topics discussed include the use of the alkylating carcinogen azoxymethane (AOM) to treat the mice, the liver morphology of the mice after 6 months of treatment and the possible use of XRCC1 mutant mouse in studying liver disease associated with epigenetic factors such as environmental exposure and diet.